Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia

Abdalla S.A., Gallione C.J., Barst R.J., Horn E.M., Knowles J.A., Marchuk D.A., Letarte M., Morse J.H.

Source: Eur Respir J 2004; 23: 373-377
Journal Issue: March
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Abdalla S.A., Gallione C.J., Barst R.J., Horn E.M., Knowles J.A., Marchuk D.A., Letarte M., Morse J.H.. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 2004; 23: 373-377

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The pulmonary vascular complications of hereditary haemorrhagic telangiectasia
Source: Eur Respir J 2009; 33: 1186-1194
Year: 2009



Endoglin germline mutation, hereditary hemorrhagic telangiectasia and fenfluramine-associated pulmonary arterial hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Prevalence of pulmonary hypertension in a large cohort of patients with hereditary hemorrhagic telangiectasia
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015

Pulmonary hypertension in hereditary hemorrhagic telangiectasia is associated with multiple clinical conditions
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Pulmonary hypertension in hereditary haemorrhagic telangiectasia is associated with multiple clinical conditions
Source: ERJ Open Res, 7 (1) 00078-2020; 10.1183/23120541.00078-2020
Year: 2021



Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001


TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020



Genetics of pulmonary hypertension: from bench to bedside
Source: Eur Respir J 2002; 20: 741-749
Year: 2002



Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Fatal rupture of pulmonary arteriovenous malformation in hereditary haemorrhagic telangiectasis and severe PAH
Source: Eur Respir Rev 2009; 18: 42-46
Year: 2009


Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005

Ortner‘s syndrome associated with secondary pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 55s
Year: 2004

Familial pulmonary arterial hypertension by KDR heterozygous loss of function
Source: Eur Respir J, 55 (4) 1902165; 10.1183/13993003.02165-2019
Year: 2020



Should we screen for hereditary pulmonary hypertension?
Source: Virtual Congress 2020 – Don't blame your parents: causes of pulmonary hypertension in early life
Year: 2020


Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

The Role of Inflammation in promoting pulmonary hypertension in idiopatchi and connective tissue disease-associated PAH
Source: Research Seminar 2008 - The Pulmonary Circulation: Scleroderma-Related Pulmonary Arterial Hypertension
Year: 2008